Regulations.gov document
26 Reference 26 Guidance Early-Phase Clinical Trials of CGT products - UCM359073
Supporting & Related Material · FDA-2018-D-2173 · posted Jul 13, 2018
Key facts
| Document ID | FDA-2018-D-2173-0029 |
|---|---|
| Title | 26 Reference 26 Guidance Early-Phase Clinical Trials of CGT products - UCM359073 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-D-2173 |
| Posted | Jul 13, 2018 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: